Steve Miller - Aug 13, 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Operating Officer
Signature
/s/ Steve Miller
Stock symbol
CPRX
Transactions as of
Aug 13, 2021
Transactions value $
-$46,616
Form type
4
Date filed
8/17/2021, 04:51 PM
Next filing
Aug 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $203K +65K +9.59% $3.12* 743K Aug 13, 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$249K -41K -5.52% $6.09 702K Aug 13, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 -65K -4.09% $0.00 1.53M Aug 13, 2021 Common Stock 65K $3.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover exercise price of options and tax withholding requirements.
F2 Options vested in three annual tranches beginning on August 28, 2015.